Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific‘s […]
NHS Begins Covid-19 Booster Vaccination Campaign
The NHS has started delivering Covid booster jabs to people in eligible groups from today, […]
New Chemotherapy-free Treatment for Bowel Cancer Made Available in Scotland
The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug pembrolizumab (Keytruda) for some adults with bowel cancer that’s […]
Rarebase Launches a Neuroscience Drug Discovery Platform Collaborating with 15 Rare Disease Patient Organizations
Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function’s […]
Roche Opens Access to Pathology Imaging Tools to Improve Patient Care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the introduction of the Roche Digital Pathology Open […]
Cycle Pharmaceuticals Launches Cycle Vita ™, a Dedicated Support Platform for Rare Disease Patients
Cycle Pharmaceuticals (Cycle) is pleased to announce the launch of its Boston-based support platform for […]
Young People Aged 12 to 15 to be Offered a COVID-19 Vaccine
People aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech […]
NHS Launches World’s Largest Trial of Cancer Blood Test
The NHS will today launch the world’s largest trial of a revolutionary new blood test […]
AbbVie and REGENXBIO Announce Eye Care Collaboration
AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced a partnership to develop and […]
Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs
The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more